MEK162
Drug timelines are a Plus or Pro feature.
17 regulatory and trial events tracked for MEK162, covering 2016-10-20 to 2025-12-04. Get the full timeline:
Most recent: Clinical Trial Update: MEK162 in Combination With Imatinib Mesylate in Patients With Untreated Advanced Gastrointestinal Stromal Tumor (GIST) [Phase 1, Phase 2]